The presence of HLA-DR B1 shared motif does not influence cyclophosphamide and methotrexate cytotoxicity in rheumatoid arthritis patients

Journal of Investigational Allergology and Clinical Immunology

Volumn 10, Issue 4, 2000, Pages 235-241

  Lacki, J K ^a   Wassmuth, R ^a   Korczowska, I ^a   Mackiewicz, S ^a   Muller, W ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Cyclophosphamide; HLA DR B1; Rheumatoid arthritis

Indexed keywords

CYCLOPHOSPHAMIDE; GOLD SALT; HLA DR ANTIGEN; METHOTREXATE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DRUG HYPERSENSITIVITY; FEMALE; GENOTYPE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; MALE; PROTEIN STRUCTURE; RHEUMATOID ARTHRITIS;

ADULT; AGED; ANTIRHEUMATIC AGENTS; ANTIRHEUMATIC AGENTS, GOLD; ARTHRITIS, RHEUMATOID; CYCLOPHOSPHAMIDE; FEMALE; HISTOCOMPATIBILITY TESTING; HLA-DR ANTIGENS; HUMAN; MALE; METHOTREXATE; MIDDLE AGE;

EID: 0033815422     PISSN: 10189068     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Rheumatoid arthritis: A medical emergency?
2. Genetic typing of patients with inflammatory arthritis at presentation can be used to predict outcome
3. The association of HLA DRB alleles with self-limiting and persistent forms of early symmetrical polyarthritis
4. HLA-DR B1 typing in rheumatoid arthritis: Predicting response to specific treatments
5. TNF-alpha gene polymorphism and gold intolerance in rheumatoid arthritis patients
6. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis
7. HLA markers and prediction of clinical course and outcome in rheumatoid arthritis
8. Rapid HLA-DR-B1 genotyping by nested PCR amplification
9. Non-radioactive oligotyping for HLA-DR1-DRw10 using polymerase chain reaction, digoxigenin-labelled oligonucleotides and chemiluminescence detection
10. Application of HLA-DR oligotyping to 110 kidney transplant patients with doubtful serological typing
11. Associations of B-cell alloantigen DRw4 with rheumatoid arthritis
12. Association of HLA shared epitope with joint damage progression in rheumatoid arthritis
13. Genetics of rheumatoid arthritis: Two separate regions in the major histocompatibility complex contribute to susceptibility to rheumatoid arthritis
14. TNF-alpha gene polymorphism does not affect clinical and radiological outcome of rheumatoid arthritis
15. The shared epitope hypothesis: An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis
16. HLA-DR4 and other genetic factors in rheumatoid arthritis
17. HLA DR4 subtype frequency in rheumatoid arthritis indicates that DR B1 is the major susceptibility locus within the human leukocyte antigen class two region
18. A variant of HLA-DR4 determines susceptibility to rheumatoid arthritis in a subset of Israeli Jews
19. Genetic typing of patients with inflammatory arthritis at presentation can be used to predict outcome
20. Does the presence of HLA-DR B1 shared motif affect progression of the disease in rheumatoid arthritis patients?
21. Association of HLA-Dw16 with rheumatoid arthritis in Yakima Indians. Futher evidence for the 'shared epitope' hypothesis
22. Association of HLA DR4 Dw15 (DRB1*0405) and DR10 with rheumatoid arthritis in the Spanish population
23. HLA markers and prediction of clinical course and outcome in rheumatoid arthritis